ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2643

Decreased Pain Level with Aging Leads to Underestimation of Disease Activity in Rheumatoid Arthritis

Yong Gil Hwang1, Juan (June) Feng2, Heather Eng3, Jason Lyons4, Anthony Fabio5 and Larry W. Moreland6, 1Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 2Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 3Epidemiology, Univ of Pittsburgh, Pittsburgh, PA, 4School of Public Health, Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, 5Department Of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 6Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Aging, Disease Activity, pain and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Rheumatoid arthritis (RA)
is most prevalent in those who are 60 years of age or older. It has not been
clearly established whether pain perception is different according to age in RA
patients. We investigated whether there is any difference in pain level to
similar synovial inflammation with aging using Modified Disease Activity Score
(MDAS), which was shown to have superior correlation with Magnetic Resonance
Image (MRI) detected synovitis.

Methods: For RA subjects enrolled in the
University of Pittsburgh Rheumatoid Arthritis
Comparative Effectiveness Registry (RACER), a cross-sectional analysis was
performed for all first visits available. Levels of inflammation were
calculated by MDAS28 score (=0.49 x ln(C-reactive protein (CRP)) + 0.15 x
Swollen joint count 28 (SJC) + 0.22 x Physician global assessment (PhGA) +1). Spearman’s correlations among pain (visual analog
scale, VAS), disease characteristics, comorbidities and American College of
Rheumatology (ACR) Core Data Set measures were calculated.  Univariate and multivariate analyses were performed to
investigate association between pain level and age. Age was categorized into 2
groups (younger RA <60, older RA ≥ 60) in regression models.
Mann-Whitney U test was used to detect differences between two age groups.

Results:  For the 740 subjects
analyzed, subject age was 61.2 ±13.7 (median ±SD) years with disease duration
of 14.4 ±12.4 years. In multivariate analyses, pain level had significant
negative association with age even after adjustment for race, gender,
comorbidities, and inflammation. (Table.1) In subjects with moderate
inflammation (defined by MDAS28 score above 50 percentile, N=370), older RA
subjects (age ≥ 60, N=189) had lower pain level, Tender Joint Count
(TJC), Patent Global Assessment (PtGA),  PhGA, , Routine Assessment of Patient Index Data 3
(RAPID3), Disease Activity Score (DAS) 28-CRP than younger subjects (age <
60, n=157) but SJC, physical health by 12-Item Short Form Health Survey (SF12)
were not different between them. SF12-Mental Health was better in older RA
subjects. (Table.2). There were no significant differences between two age groups
in subjects with lower levels of inflammation (MDAS ≤ 50 percentile,
N=370).  

Conclusion:   Decreased pain level in
older RA patients with a similar degree of joint inflammation as younger RA
patients leads to under-estimation of disease activity measured by either
patient reported outcome (RAPID3) or composite disease activity index
(DAS28-CRP). This suggests that current clinical disease activity measurements
may not fully reflect the severity of disease in older RA patients.

 

 Table.1 Multiple regression analyses of the associations of pain level with age adjusted for influences of covariates. Model 1 was adjusted for race, gender, comorbidities, and disease duration.  Model 2 was adjusted as model 1 plus MDAS28. Model 3 was adjusted as model 2 plus physical & mental health (β: unstandardized coefficient, SE: Standard Error, MDAS28: Modified Disease Activity Score, 12-Item Short Form Health Survey (SF12)- Physical Health(PCS), Mental Health (MCS))

Model

Variables

β

SE

p value

1

Age

-0.722

.008

0.014

Race

1.199

.349

0.003

Gender

-0..122

.259

.684

Charlson Score

0.174

.083

.016

Disease duration

-0.122

.000

.848

2

Age

-0.700

0.270

.010

Race

.989

.334

.003

Gender

-0.171

.238

.474

Charlson Score

0.146

.075

.053

Disease duration

0.000

.0.000

0.366

MDAS28

0.735

.065

.000

3

Age

-.602

.163

    .000

Race

.619

.253

.015

Gender

-.016

.187

.931

Charlson score

.050

.060

.404

Disease duration

0.000

.001

.961

MDAS28

.314

.055

.000

SF12-PCS

-.147

.008

.000

SF12-MCS

-.071

.007

.000

 

 

 Table. 2 Comparisons between younger (age<60,n=157) and older (age>=60, n=189) RA patients with moderate inflammation (MDAS28 >50 percentile)  (SJC: Swollen Joint Count, TJC: Tender Joint Count, PtGA: Patient Global Assessment, PhGA: Physician Global Assessment, SF12-PCS/MCS: 12-Item Short Form Health Survey (SF12)- Physical Health(PCS), Mental Health (MCS), DAS28-CRP: Disease Activity Score 28-C-Reactive Protein, RAPID3: Routine Assessment of Patient Index 3)

 

 

 Unadjusted (Mean ± SD)

Adjusted (Mean ± SD)

 

Age < 60

Age ≥ 60

p value*

Age < 60

Age ≥ 60

p value*

Pain (VAS)

6.36 (2.59)

5.14 (2.75)

<0.001

6.16 (1.87)

5.06 (1.80)

<0.001

SJC

6.76 (5.92)

6.88 (6.00)

0.963

7.36 (3.85)

7.06 (3.59)

0.521

TJC

6.74 (6.65)

4.20 (5.46)

<0.001

6.70 (2.89)

4.84 (2.71)

<0.001

PtGA

5.56 (2.35)

4.44 (2.50)

<0.001

5.35 (1.78)

4.52 (1.67)

<0.001

PhGA

4.89 (2.37)

3.97 (2.27)

<0.001

4.64 (1.67)

4.03 (1.56)

<0.001

RAPID3

4.51 (1.17)

3.98 (1.09)

<0.001

4.79 (1.62)

4.04 (1.56)

<0.001

DAS28-CRP

4.94 (2.01)

4.04 (2.02)

<0.001

4.38 (1.02)

3.97 (0.96)

<0.001

SF12-PCS

34.77 (9.88)

35.27 (10.34)

0.697

 

SF12-MCS

44.27 (11.58)

49.27 (10.93)

<0.001

 

*  p values < 0.0056 were considered statistically significant using the Bonferroni correction for multiple comparisons

 

 


Disclosure: Y. G. Hwang, None; J. Feng, None; H. Eng, None; J. Lyons, None; A. Fabio, None; L. W. Moreland, None.

To cite this abstract in AMA style:

Hwang YG, Feng J, Eng H, Lyons J, Fabio A, Moreland LW. Decreased Pain Level with Aging Leads to Underestimation of Disease Activity in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/decreased-pain-level-with-aging-leads-to-underestimation-of-disease-activity-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decreased-pain-level-with-aging-leads-to-underestimation-of-disease-activity-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology